Group 1 - The complexity of blood cancer classification presents numerous investment opportunities in various subtypes of treatment [1] - The promotion and application of emerging treatment methods such as targeted therapy, immunotherapy, and cell therapy have led to a trend in blood cancer treatment similar to chronic disease management for hypertension and diabetes [1] - The long survival cycle of blood cancer patients results in a large existing patient population, coupled with high drug treatment costs, leading to the emergence of blockbuster products and significant potential market opportunities [1]